Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Loftus EV Jr"" wg kryterium: Autor


Tytuł :
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1
Autorzy :
Loftus EV Jr
Sands BE
Colombel JF
Dotan I
Khalid JM
Tudor D
Geransar P
Pokaż więcej
Temat :
vedolizumab
ulcerative colitis
corticosteroid
anti-tumor necrosis factor alpha
clinical remission
Diseases of the digestive system. Gastroenterology
RC799-869
Źródło :
Clinical and Experimental Gastroenterology, Vol Volume 13, Pp 211-220 (2020)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/sustained-corticosteroid-free-clinical-remission-during-vedolizumab-ma-peer-reviewed-article-CEG; https://doaj.org/toc/1178-7023
Dostęp URL :
https://doaj.org/article/25ed36172168450dba44eeba60012403
Czasopismo naukowe
Tytuł :
Ustekinumab in treatment of Crohn’s disease: design, development, and potential place in therapy
Autorzy :
Deepak P
Loftus EV Jr
Pokaż więcej
Temat :
Ustekinumab
Crohn’s disease
inflammatory bowel disease
Interleukin-12/23 monoclonal antibody
Interleukin-12
Interleukin-23
Therapeutics. Pharmacology
RM1-950
Źródło :
Drug Design, Development and Therapy, Vol Volume 10, Pp 3685-3698 (2016)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/ustekinumab--in-treatment-of-crohnrsquos-disease-design-development-an-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL :
https://doaj.org/article/0d24f01154664be99807e918cec412cf
Czasopismo naukowe
Tytuł :
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.
Autorzy :
Lee SD; Digestive Health Center, University of Washington Medical Center, Seattle, WA.
Shivashankar R; Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia.
Quirk D; Pfizer Inc., Cambridge, MA.
Zhang H; Pfizer Inc., Collegeville, PA.
Telliez JB; Pfizer Inc., Cambridge, MA.
Andrews J; Pfizer Inc., Cambridge, MA.
Marren A; Pfizer Inc., Cambridge, MA.
Mukherjee A; Pfizer Inc., Groton, CT.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło :
Journal of clinical gastroenterology [J Clin Gastroenterol] 2021 Mar 01; Vol. 55 (3), pp. 195-206.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center.
Autorzy :
Kwapisz L; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Raffals LE; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: .
Bruining DH; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Pardi DS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Tremaine WJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Kane SV; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Papadakis KA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Coelho-Prabhu N; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Kisiel JB; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Heron V; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Faubion WA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Mar; Vol. 19 (3), pp. 616-617. Date of Electronic Publication: 2020 Feb 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.
Autorzy :
Barnes EL; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Multidisciplinary Center for Inflammatory Bowel Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: .
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Kappelman MD; Multidisciplinary Center for Inflammatory Bowel Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Division of Pediatric Gastroenterology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Pokaż więcej
Źródło :
Gastroenterology [Gastroenterology] 2021 Feb; Vol. 160 (3), pp. 677-689. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Isolated Colonic Post-Transplantation Lymphoproliferative Disease.
Autorzy :
Fredrick T; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Piovezani Ramos G; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Jan 29. Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.
Autorzy :
Sinh P; Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, Hub for Collaborative Medicine, Milwaukee, WI, 53226, USA.; Division of Gastroenterology and Liver Diseases, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH, 44106, USA.
Tabibian JH; Division of Gastroenterology, Department of Medicine, UCLA-Olive View Medical Center, 14445 Olive View Dr. 2B182, Sylmar, CA, 91342, USA.
Biyani PS; Ohio Gastroenterology Group, 3400 Olentangy River Rd, Columbus, OH, 43202, USA.
Mehta K; Division of Medical Oncology, Kansas University Medical Center, 2330, Shawnee Mission Parkway, Westwood, KS, 66205, USA.
Mansoor E; Division of Gastroenterology and Liver Diseases, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH, 44106, USA.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Dave M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, UC Davis Health, University of California Davis School of Medicine, 4150 V Street, Ste 3500, Sacramento, CA, 95817, USA. .
Pokaż więcej
Źródło :
Digestive diseases and sciences [Dig Dis Sci] 2021 Jan 25. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
Autorzy :
Jansson-Knodell CL; Division of Gastroenterology and Hepatology, Indiana University, 702 Rotary Circle, Suite 225, Indianapolis, IN, 46202, USA.; Department of Internal Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Harris CE; Department of Internal Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Walker RC; Division of Infectious Diseases, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Enzler MJ; Division of Infectious Diseases, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Virk A; Division of Infectious Diseases, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. .
Pokaż więcej
Źródło :
Digestive diseases and sciences [Dig Dis Sci] 2021 Jan; Vol. 66 (1), pp. 190-198. Date of Electronic Publication: 2020 Mar 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Nonbiologic Immune Suppression in Ulcerative Colitis.
Autorzy :
Heron V; Department of Gastroenterology, University of Montreal, Hopital Maisonneuve-Rosemont, 5415 Boulevard de l'Assomption, Montreal, Quebec H1I 2M4, Canada.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street, Southwest, Rochester, MN 55905, USA. Electronic address: loftus..
Pokaż więcej
Źródło :
Gastroenterology clinics of North America [Gastroenterol Clin North Am] 2020 Dec; Vol. 49 (4), pp. 731-738. Date of Electronic Publication: 2020 Sep 19.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
Autorzy :
Azzam N; Division of Gastroenterology, Department of Medicine, King Saud University Medical City, King Saud University, Po Box 2925, 12372, Riyadh, Kingdom of Saudi Arabia. .
AlRuthia Y; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Po Box 2925, 12372, Riyadh, Kingdom of Saudi Arabia.; Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Po Box 2925, 12372, Riyadh, Kingdom of Saudi Arabia.
Alharbi O; Division of Gastroenterology, Department of Medicine, King Saud University Medical City, King Saud University, Po Box 2925, 12372, Riyadh, Kingdom of Saudi Arabia.
Aljebreen A; Division of Gastroenterology, Department of Medicine, King Saud University Medical City, King Saud University, Po Box 2925, 12372, Riyadh, Kingdom of Saudi Arabia.
Almadi M; Division of Gastroenterology, Department of Medicine, King Saud University Medical City, King Saud University, Po Box 2925, 12372, Riyadh, Kingdom of Saudi Arabia.; Division of Gastroenterology, The McGill University Health Center, Montreal General Hospital, 1001 Decarie Blvd, Montreal, QC, H4A3J1, Canada.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA.
Pokaż więcej
Źródło :
Hepatology international [Hepatol Int] 2020 Dec; Vol. 14 (6), pp. 1114-1124. Date of Electronic Publication: 2020 Dec 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Autorzy :
Dulai PS; Division of Gastroenterology, University of California, San Diego, La Jolla, California. Electronic address: .
Singh S; Division of Gastroenterology, University of California, San Diego, La Jolla, California.
Casteele NV; Division of Gastroenterology, University of California, San Diego, La Jolla, California.
Meserve J; Division of Gastroenterology, University of California, San Diego, La Jolla, California.
Winters A; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Chablaney S; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Aniwan S; Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota.
Shashi P; Division of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio.
Kochhar G; Division of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio.
Weiss A; Division of Gastroenterology, Montefiore Medical Center, Bronx, New York.
Koliani-Pace JL; Division of Gastroenterology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Gao Y; Division of Gastroenterology, North Shore University Hospital, Manhasset, New York.
Boland BS; Division of Gastroenterology, University of California, San Diego, La Jolla, California.
Chang JT; Division of Gastroenterology, University of California, San Diego, La Jolla, California.
Faleck D; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Hirten R; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Ungaro R; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Lukin D; Division of Gastroenterology, Montefiore Medical Center, Bronx, New York.
Sultan K; Division of Gastroenterology, North Shore University Hospital, Manhasset, New York.
Hudesman D; Division of Gastroenterology, New York University, New York, New York.
Chang S; Division of Gastroenterology, New York University, New York, New York.
Bohm M; Division of Gastroenterology, Indiana University, Indianapolis, Indiana.
Varma S; Division of Gastroenterology, Indiana University, Indianapolis, Indiana.
Fischer M; Division of Gastroenterology, Indiana University, Indianapolis, Indiana.
Shmidt E; Division of Gastroenterology, University of Minnesota, Minneapolis, Minnesota.
Swaminath A; Division of Gastroenterology, Lenox Hill Hospital, New York, New York.
Gupta N; Division of Gastroenterology, University of Mississippi, Jackson, Mississippi.
Rosario M; Takeda Pharmaceuticals USA, Deerfield, Illinois.
Jairath V; Division of Gastroenterology, University of Western Ontario, London, Ontario, Canada.
Guizzetti L; Robarts Clinical Trials, London, Ontario, Canada.
Feagan BG; Division of Gastroenterology, University of Western Ontario, London, Ontario, Canada.
Siegel CA; Division of Gastroenterology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Shen B; Division of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio.
Kane S; Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota.
Loftus EV Jr; Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota.
Sandborn WJ; Division of Gastroenterology, University of California, San Diego, La Jolla, California.
Sands BE; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Colombel JF; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Lasch K; Takeda Pharmaceuticals USA, Deerfield, Illinois.
Cao C; Takeda Pharmaceuticals USA, Deerfield, Illinois.
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2020 Dec; Vol. 18 (13), pp. 2952-2961.e8. Date of Electronic Publication: 2020 Feb 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme.
Autorzy :
Winthrop KL; Oregon Health & Science University, Portland , OR,  USA.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester , MN,  USA.
Baumgart DC; Division of Gastroenterology, University of Alberta, Edmonton , AB,  Canada.
Reinisch W; Medical University of Vienna , Vienna,  Austria.
Nduaka CI; Pfizer Inc, Collegeville , PA,  USA.
Lawendy N; Pfizer Inc, Collegeville , PA,  USA.
Chan G; Pfizer Inc, Collegeville , PA,  USA.
Mundayat R; Pfizer Inc, New York , NY,  USA.
Friedman GS; Pfizer Inc, Collegeville , PA,  USA.
Salese L; Pfizer Inc, Collegeville , PA,  USA.
Thorpe AJ; Pfizer Inc, Collegeville , PA,  USA.
Su C; Pfizer Inc, Collegeville , PA,  USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Nov 27. Date of Electronic Publication: 2020 Nov 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Combined Fasting Serum C4 and Primary Bile Acids From a Single Stool Sample to Diagnose Bile Acid Diarrhea.
Autorzy :
Vijayvargiya P; Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Mayo Clinic, Rochester, Minnesota; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Camilleri M; Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Mayo Clinic, Rochester, Minnesota; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: .
Taylor A; Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Mayo Clinic, Rochester, Minnesota; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Busciglio I; Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Mayo Clinic, Rochester, Minnesota; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Donato LJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
Gastroenterology [Gastroenterology] 2020 Nov; Vol. 159 (5), pp. 1952-1954.e2. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Autorzy :
Lukin D; Montefiore Medical Center, New York, New York.
Faleck D; Icahn School of Medicine at Mount Sinai, New York, New York.
Xu R; University of California, San Diego, La Jolla, California.
Zhang Y; University of California, San Diego, La Jolla, California.
Weiss A; Montefiore Medical Center, New York, New York.
Aniwan S; Mayo Clinic, Rochester, Minnesota.
Kadire S; Indiana University, Indianapolis, Indiana.
Tran G; Indiana University, Indianapolis, Indiana.
Rahal M; Indiana University, Indianapolis, Indiana.
Winters A; Icahn School of Medicine at Mount Sinai, New York, New York.
Chablaney S; Icahn School of Medicine at Mount Sinai, New York, New York.
Koliani-Pace JL; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Meserve J; University of California, San Diego, La Jolla, California.
Campbell JP; University of Minnesota, Minneapolis, Minnesota.
Kochhar G; Cleveland Clinic Foundation, Cleveland, Ohio.
Bohm M; Indiana University, Indianapolis, Indiana.
Varma S; Indiana University, Indianapolis, Indiana.
Fischer M; Indiana University, Indianapolis, Indiana.
Boland B; University of California, San Diego, La Jolla, California.
Singh S; University of California, San Diego, La Jolla, California.
Hirten R; Icahn School of Medicine at Mount Sinai, New York, New York.
Ungaro R; Icahn School of Medicine at Mount Sinai, New York, New York.
Lasch K; Takeda Pharmaceuticals, Lexington, Massachusetts.
Shmidt E; University of Minnesota, Minneapolis, Minnesota.
Jairath V; University of Western Ontario, London, Ontario, Canada.
Hudesman D; New York University, New York, New York.
Chang S; New York University, New York, New York.
Swaminath A; Lenox Hill Hospital, New York, New York.
Shen B; Cleveland Clinic Foundation, Cleveland, Ohio.
Kane S; Mayo Clinic, Rochester, Minnesota.
Loftus EV Jr; Mayo Clinic, Rochester, Minnesota.
Sands BE; Icahn School of Medicine at Mount Sinai, New York, New York.
Colombel JF; Icahn School of Medicine at Mount Sinai, New York, New York.
Siegel CA; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Sandborn WJ; University of California, San Diego, La Jolla, California.
Dulai PS; University of California, San Diego, La Jolla, California. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2020 Oct 08. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long-term safety of vedolizumab for inflammatory bowel disease.
Autorzy :
Loftus EV Jr; Rochester, MN, USA.
Feagan BG; London, ON, Canada.
Panaccione R; Calgary, AB, Canada.
Colombel JF; New York, NY, USA.
Sandborn WJ; San Diego, CA, USA.
Sands BE; New York, NY, USA.
Danese S; Milan, Italy.
D'Haens G; Amsterdam, The Netherlands.
Rubin DT; Chicago, IL, USA.
Shafran I; Winter Park, FL, USA.
Parfionovas A; Cambridge, MA, USA.
Rogers R; Cambridge, MA, USA.
Lirio RA; Cambridge, MA, USA.
Vermeire S; Leuven, Belgium.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Oct; Vol. 52 (8), pp. 1353-1365. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal, Humanized/*adverse effects
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Inflammatory Bowel Diseases/*drug therapy
Inflammatory Bowel Diseases/*epidemiology
Adult ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Cohort Studies ; Colitis, Ulcerative/drug therapy ; Colitis, Ulcerative/epidemiology ; Crohn Disease/drug therapy ; Crohn Disease/epidemiology ; Female ; Follow-Up Studies ; Gastrointestinal Agents/administration & dosage ; Gastrointestinal Agents/adverse effects ; Humans ; Male ; Middle Aged ; Quality of Life ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Comparison of Disease-related Knowledge of Patients With Inflammatory Bowel Disease Between the West and the East Using an Updated Questionnaire (IBD-KNOW).
Autorzy :
Kim JY; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
Yoon H; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea.
Hwang JS; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
Yang SK; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
Park SH; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul.; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło :
Journal of clinical gastroenterology [J Clin Gastroenterol] 2020 Sep; Vol. 54 (8), pp. 720-724.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.
Autorzy :
Bohm M; Indianapolis, IN, USA.
Xu R; La Jolla, CA, USA.
Zhang Y; La Jolla, CA, USA.
Varma S; Indianapolis, IN, USA.
Fischer M; Indianapolis, IN, USA.
Kochhar G; Cleveland, OH, USA.
Boland B; La Jolla, CA, USA.
Singh S; La Jolla, CA, USA.
Hirten R; New York, NY, USA.
Ungaro R; New York, NY, USA.
Shmidt E; Minneapolis, MN, USA.
Lasch K; Deerfield, IL, USA.
Jairaith V; London, ON, Canada.
Hudesman D; New York, NY, USA.
Chang S; New York, NY, USA.
Lukin D; New York, NY, USA.
Swaminath A; New York, NY, USA.
Sands BE; New York, NY, USA.
Colombel JF; New York, NY, USA.
Kane S; Rochester, MN, USA.
Loftus EV Jr; Rochester, MN, USA.
Shen B; Cleveland, OH, USA.
Siegel CA; Lebanon, NH, USA.
Sandborn WJ; La Jolla, CA, USA.
Dulai PS; La Jolla, CA, USA.
Pokaż więcej
Corporate Authors :
VICTORY Collaboration
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Aug; Vol. 52 (4), pp. 669-681. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji :
Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Crohn Disease/*drug therapy
Tumor Necrosis Factor Inhibitors/*therapeutic use
Adalimumab/therapeutic use ; Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; Certolizumab Pegol/therapeutic use ; Cohort Studies ; Crohn Disease/epidemiology ; Female ; Humans ; Infliximab/therapeutic use ; Middle Aged ; Remission Induction ; Retrospective Studies ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors/adverse effects ; Young Adult
Czasopismo naukowe
Tytuł :
Are Biologics Safe in the Immediate Postoperative Period? A Single-Center Evaluation of Consecutive Crohn's Surgical Patients.
Autorzy :
Lightner AL; Division of Colorectal Surgery, Cleveland Clinic, Cleveland, Ohio.; Department of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.
Grass F; Department of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.; Department of Visceral Surgery, Lausanne University Hospital, Lausanne, Switzerland.
Alsughayer AM; Department of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.
Harmsen WS; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Petersen M; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
Diseases of the colon and rectum [Dis Colon Rectum] 2020 Jul; Vol. 63 (7), pp. 934-943.
Typ publikacji :
Journal Article; Webcast
MeSH Terms :
Biological Products/*adverse effects
Crohn Disease/*therapy
Postoperative Care/*methods
Tumor Necrosis Factor Inhibitors/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Biological Products/therapeutic use ; Case-Control Studies ; Female ; Humans ; Immunologic Factors/adverse effects ; Immunologic Factors/therapeutic use ; Intraabdominal Infections/epidemiology ; Male ; Middle Aged ; Postoperative Care/statistics & numerical data ; Postoperative Complications/microbiology ; Postoperative Period ; Retrospective Studies ; Safety ; Surgical Wound Infection/epidemiology ; Tumor Necrosis Factor Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł :
Use of Immune Checkpoint Inhibitors in Patients With Pre-established Inflammatory Bowel Diseases: Retrospective Case Series.
Autorzy :
Braga Neto MB; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Ramos GP; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Faubion WA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Raffals LE; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2020 Jun 19. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies